Original Articles
19 September 2014

Metabolic syndrome and heart failure: data from the FADOI CONFINE study

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
1960
Views
860
Downloads
293
HTML

Authors

Approximately 20%-30% of the population in industrialized countries suffers from metabolic syndrome (MetS), a condition that may double the risk of diabetes mellitus and heart diseases in the normal population. Both MetS per se and its components increase the risk of atherosclerosis and acute coronary artery disease and heart failure (HF). We reviewed the data from a recent survey of patients admitted to Italian internal medicine wards due to chronic heart failure to ascertain the prevalence and the relationships between MetS and HF in real life patients. Our data shows that some risk factors for this syndrome (above all obesity) reflect a sort of Janus phenomenon in that they are well-recognized risk factors for HF in young people, but they lose their unfavorable predictive value in elderly patients with HF.

Altmetrics

Downloads

Download data is not yet available.

Citations

How to Cite



Metabolic syndrome and heart failure: data from the FADOI CONFINE study. (2014). Italian Journal of Medicine, 8(3), 169-175. https://doi.org/10.4081/itjm.2014.406